These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 21182232

  • 1. Pegylated interferon α-2b up-regulates specific CD8+ T cells in patients with chronic hepatitis B.
    Chen J, Wang Y, Wu XJ, Li J, Hou FQ, Wang GQ.
    World J Gastroenterol; 2010 Dec 28; 16(48):6145-50. PubMed ID: 21182232
    [Abstract] [Full Text] [Related]

  • 2. Pegylated interferon α enhances recovery of memory T cells in e antigen positive chronic hepatitis B patients.
    Liu YZ, Hou FQ, Ding P, Ren YY, Li SH, Wang GQ.
    Virol J; 2012 Nov 16; 9():274. PubMed ID: 23158844
    [Abstract] [Full Text] [Related]

  • 3. The reduction in CD8+PD-1+ T cells in liver histological tissue is related to Pegylated IFN-α therapy outcomes in chronic hepatitis B patients.
    Liu R, Chen Y, Guo J, Li M, Lu Y, Zhang L, Shen G, Wu S, Chang M, Hu L, Hao H, Zhang H, Xie Y.
    BMC Infect Dis; 2020 Aug 10; 20(1):590. PubMed ID: 32778058
    [Abstract] [Full Text] [Related]

  • 4. Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B.
    Micco L, Peppa D, Loggi E, Schurich A, Jefferson L, Cursaro C, Panno AM, Bernardi M, Brander C, Bihl F, Andreone P, Maini MK.
    J Hepatol; 2013 Feb 10; 58(2):225-33. PubMed ID: 23046671
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of interferon alpha-2b versus pegylated interferon alpha-2a monotherapy in children with chronic hepatitis B: a real-life cohort study from Shanghai, China.
    Hu Y, Ye YZ, Ye LJ, Wang XH, Yu H.
    World J Pediatr; 2019 Dec 10; 15(6):595-600. PubMed ID: 31487005
    [Abstract] [Full Text] [Related]

  • 6. Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy.
    Tseng TC, Yu ML, Liu CJ, Lin CL, Huang YW, Hsu CS, Liu CH, Kuo SF, Pan CJ, Yang SS, Su CW, Chen PJ, Chen DS, Kao JH.
    Antivir Ther; 2011 Dec 10; 16(5):629-37. PubMed ID: 21817184
    [Abstract] [Full Text] [Related]

  • 7. [Clinical effect and safety of pegylated interferon-α-2b injection (Y shape, 40 kD) in treatment of HBeAg-positive chronic hepatitis B patients].
    Hou FQ, Yin YL, Zeng LY, Shang J, Gong GZ, Pan C, Zhang MX, Yin CB, Xie Q, Peng YZ, Chen SJ, Mao Q, Chen YP, Mao QG, Zhang DZ, Han T, Wang MR, Zhao W, Liu JJ, Han Y, Zhao LF, Luo GH, Zhang JM, Peng J, Tan DM, Li ZW, Tang H, Wang H, Zhang YX, Li J, Zhang LL, Chen L, Jia JD, Chen CW, Zhen Z, Li BS, Niu JQ, Meng QH, Yuan H, Sun YT, Li SC, Sheng JF, Cheng J, Sun L, Wang GQ.
    Zhonghua Gan Zang Bing Za Zhi; 2017 Aug 20; 25(8):589-596. PubMed ID: 29056008
    [Abstract] [Full Text] [Related]

  • 8. Ribavirin and IFN-alpha combination therapy induces CD4+ T-cell proliferation and Th1 cytokine secretion in patients with chronic hepatitis B.
    Ren FY, Jin H, Piao XX, Piao FS.
    World J Gastroenterol; 2007 Nov 07; 13(41):5440-5. PubMed ID: 17907286
    [Abstract] [Full Text] [Related]

  • 9. Hepatitis B virus-specific T-cell responses during IFN administration in a small cohort of chronic hepatitis B patients under nucleos(t)ide analogue treatment.
    Sprinzl MF, Russo C, Kittner J, Allgayer S, Grambihler A, Bartsch B, Weinmann A, Galle PR, Schuchmann M, Protzer U, Bauer T.
    J Viral Hepat; 2014 Nov 07; 21(9):633-41. PubMed ID: 24251783
    [Abstract] [Full Text] [Related]

  • 10. The comparison of the efficacy of pegylated interferon α-2a and α-2b in chronic hepatitis B patients.
    Dogan UB, Golge N, Akin MS.
    Eur J Gastroenterol Hepatol; 2013 Nov 07; 25(11):1312-6. PubMed ID: 23652913
    [Abstract] [Full Text] [Related]

  • 11. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
    Shepherd J, Jones J, Takeda A, Davidson P, Price A.
    Health Technol Assess; 2006 Aug 07; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
    [Abstract] [Full Text] [Related]

  • 12. Peginterferon alfa-2b as monotherapy or in combination with lamivudine in patients with HBeAg-negative chronic hepatitis B: a randomised study.
    Papadopoulos VP, Chrysagis DN, Protopapas AN, Goulis IG, Dimitriadis GT, Mimidis KP.
    Med Sci Monit; 2009 Feb 07; 15(2):CR56-61. PubMed ID: 19179968
    [Abstract] [Full Text] [Related]

  • 13. [Changes in lymphocyte surface expression of CD8 and CD38 molecules in peripheral blood of inactive HBsAg carriers following pegylated interferon a-2a therapy].
    Yu HB, Ma LN, Liu YL, Hua W, He ZM, Lu JF, Chen XY.
    Zhonghua Gan Zang Bing Za Zhi; 2013 Dec 07; 21(12):895-8. PubMed ID: 24636289
    [Abstract] [Full Text] [Related]

  • 14. [Alterations of IFN-γ and IL-4 of peripheral blood T cells in patients with chronic HBV infection].
    Li M, Sun X, Zhou Z, Zhang X, Jin S, Gao Y, Gao Y.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb 07; 32(2):240-4. PubMed ID: 26927386
    [Abstract] [Full Text] [Related]

  • 15. Pegylated Interferon α-2a Triggers NK-Cell Functionality and Specific T-Cell Responses in Patients with Chronic HBV Infection without HBsAg Seroconversion.
    Bruder Costa J, Dufeu-Duchesne T, Leroy V, Bertucci I, Bouvier-Alias M, Pouget N, Brevot-Lutton O, Bourliere M, Zoulim F, Plumas J, Aspord C, ANRS HB06 PEGAN study group.
    PLoS One; 2016 Feb 07; 11(6):e0158297. PubMed ID: 27348813
    [Abstract] [Full Text] [Related]

  • 16. Interleukin-35 Suppresses Antiviral Immune Response in Chronic Hepatitis B Virus Infection.
    Shao X, Ma J, Jia S, Yang L, Wang W, Jin Z.
    Front Cell Infect Microbiol; 2017 Feb 07; 7():472. PubMed ID: 29181338
    [Abstract] [Full Text] [Related]

  • 17. Taurocholic acid inhibits the response to interferon-α therapy in patients with HBeAg-positive chronic hepatitis B by impairing CD8+ T and NK cell function.
    Xun Z, Lin J, Yu Q, Liu C, Huang J, Shang H, Guo J, Ye Y, Wu W, Zeng Y, Wu S, Xu S, Chen T, Chen J, Ou Q.
    Cell Mol Immunol; 2021 Feb 07; 18(2):461-471. PubMed ID: 33432062
    [Abstract] [Full Text] [Related]

  • 18. Pegylated-interferon alpha therapy for treatment-experienced chronic hepatitis B patients.
    Yeh ML, Peng CY, Dai CY, Lai HC, Huang CF, Hsieh MY, Huang JF, Chen SC, Lin ZY, Yu ML, Chuang WL.
    PLoS One; 2015 Feb 07; 10(4):e0122259. PubMed ID: 25835020
    [Abstract] [Full Text] [Related]

  • 19. Clinical Analysis of Polyethylene Glycol Interferon-α Treatment in 155 Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis B (CHB) Patients.
    Luo X, Yu JX, Xie L, Ma WJ, Wang LH.
    Ann Hepatol; 2015 Feb 07; 16(6):888-892. PubMed ID: 29055925
    [Abstract] [Full Text] [Related]

  • 20. [Dynamic changes of B7-H1 expression on mDCs and T cells in chronic hepatitis B patients treated with PEG-IFN alpha-2a].
    Li YG, Chen LE, Chen GF, Wang FS.
    Zhonghua Gan Zang Bing Za Zhi; 2008 Jun 07; 16(6):421-4. PubMed ID: 18578991
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.